SIRT1 and obesity disorder: It was demonstrated that SIRT1, an NAD+ dependent type III deacetylase sirtuin, potentiates BAT function enhancing glucose tolerance (Boutant et al., 2015) and inducing resistance to obesity (Wang et al., 2013).